PARSONS CAPITAL MANAGEMENT INC/RI - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 8 filers reported holding CHINA PHARMA HLDGS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PARSONS CAPITAL MANAGEMENT INC/RI ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2019$2,0000.0%10,0000.0%0.00%
Q3 2019$2,000
-33.3%
10,0000.0%0.00%
Q2 2019$3,0000.0%10,0000.0%0.00%
Q1 2019$3,0000.0%10,0000.0%0.00%
Q4 2018$3,000
+50.0%
10,0000.0%0.00%
Q3 2018$2,0000.0%10,0000.0%0.00%
Q2 2018$2,000
-33.3%
10,0000.0%0.00%
Q1 2018$3,000
+50.0%
10,0000.0%0.00%
Q4 2017$2,0000.0%10,0000.0%0.00%
Q3 2017$2,0000.0%10,0000.0%0.00%
Q2 2017$2,000
-33.3%
10,0000.0%0.00%
Q1 2017$3,0000.0%10,0000.0%0.00%
Q4 2016$3,000
+50.0%
10,0000.0%0.00%
Q3 2016$2,0000.0%10,0000.0%0.00%
Q1 2016$2,0000.0%10,0000.0%0.00%
Q4 2015$2,0000.0%10,0000.0%0.00%
Q3 2015$2,000
-50.0%
10,0000.0%0.00%
-100.0%
Q2 2015$4,00010,0000.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q4 2019
NameSharesValueWeighting ↓
POPE ASSET MANAGEMENT, LLC 2,104,826$632,0000.51%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 1,290,463$387,0000.07%
GLENHILL ADVISORS LLC 200,000$60,0000.01%
Renaissance Technologies 136,300$41,0000.00%
Virtu KCG Holdings LLC 19,910$6,0000.00%
UBS Group AG 5,618$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders